NEW YORK (GenomeWeb News) — Agilent Technologies today said it expects third-quarter revenue to decline between 2 percent and 4.8 percent year over year, or to between $1.38 billion and $1.42 billion from $1.45 billion last year.
 
The company also said it has closed its acquisition of Stratagene for $10.94 a share, or $246 million.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.